|
Status |
Public on Mar 07, 2015 |
Title |
Gene expression profiling of effect of Yap inhibition in a genetically engineered mouse model of hepatocellular carcinoma |
Organism |
Mus musculus |
Experiment type |
Expression profiling by high throughput sequencing
|
Summary |
Defective Hippo/YAP signaling in the liver results in tissue overgrowth and development of hepatocellular carcinoma (HCC). Here, we uncover mechanisms of YAP-mediated hepatocyte reprogramming and HCC pathogenesis. We show that YAP functions as a rheostat maintaining metabolic specialization, differentiation and quiescence within the hepatocyte compartment. Importantly, treatment with siRNA-lipid nanoparticles (siRNA-LNPs) targeting YAP restores hepatocyte differentiation and causes pronounced tumor regression in a genetically engineered mouse HCC model (mice with liver-specific Mst1/Mst2 double knockout). Furthermore, YAP targets are enriched in an aggressive human HCC subtype characterized by a proliferative signature and absence of CTNNB1 mutations. Thus, our work reveals Hippo signaling as a key regulator of positional identity of hepatocytes, supports targeting YAP using siRNA-LNPs as a paradigm of differentiation-based therapy, and identifies an HCC subtype potentially responsive to this approach.
|
|
|
Overall design |
Mice with liver-specific Mst1/Mst2 double-knockout (Adeno-Cre injected Mst1-/-; Mst2Flox/Flox mice) were monitored for the formation of HCC by ultrasound imaging. Animals were then randomized to be treated by intravenous injection of either siYap-LNPs or siLuciferase-LNPs for a period of 9 days.
|
|
|
Contributor(s) |
Fitamant J, Bardeesy N, Ross KN |
Citation(s) |
25772357 |
|
Submission date |
Feb 05, 2015 |
Last update date |
May 15, 2019 |
Contact name |
Kenneth N Ross |
E-mail(s) |
Kenneth.Ross@dfci.harvard.edu
|
Organization name |
Dana-Farber Cancer Institute
|
Department |
Pediatric Oncology
|
Street address |
450 Brookline Ave., Rm M640
|
City |
Boston |
State/province |
MA |
ZIP/Postal code |
02115 |
Country |
USA |
|
|
Platforms (1) |
GPL17021 |
Illumina HiSeq 2500 (Mus musculus) |
|
Samples (13)
|
|
Relations |
BioProject |
PRJNA274661 |
SRA |
SRP053235 |